Alexander: Regenerative Medicine, LDTs, Device Surveillance Will Be Debated On Floor

Senate health committee chair Lamar Alexander (R-TN) said at the committee’s final markup of health innovation bills Wednesday (April 6) that proposals to give FDA authority to conditionally approve cellular therapies, improve post-market monitoring of medical devices and address the contentious issue of laboratory developed tests may be debated on the Senate floor. Alexander additionally said the committee is working to find an amount of mandatory funding for National Institutes Health priorities that the House will agree to and the...